Heparan sulfate selectively inhibits the collagenase activity of cathepsin K
Matrix Biology · 2024
DOI: 10.1016/j.matbio.2024.03.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Matrix Biology, 2024. Verfasst von Xiaoxiao Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Biology, School of Dental Medicine, University at Buffalo, the State University of New York, Buffalo, NY 14214, USA. Hauptthemen laut MEDLINE: Cathepsin K, Heparan Sulfate, Collagenases, Osteoclasts. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Intramural NIH HHS, NIDCR NIH HHS.
Abstract (Originalsprache)
Cathepsin K (CtsK) is a cysteine protease with potent collagenase activity. CtsK is highly expressed by bone-resorbing osteoclasts and plays an essential role in resorption of bone matrix. Although CtsK is known to bind heparan sulfate (HS), the structural details of the interaction, and how HS regulates the biological functions of CtsK, remains largely unknown. In this report, we discovered that HS is a multifaceted regulator of the structure and function of CtsK. Structurally, HS forms a highly stable complex with CtsK and induces its dimerization. Co-crystal structures of CtsK with bound HS oligosaccharides reveal the location of the HS binding site and suggest how HS may support dimerization. Functionally, HS plays a dual role in regulating the enzymatic activity of CtsK. While it preserves the peptidase activity of CtsK by stabilizing its active conformation, it inhibits the collagenase activity of CtsK in a sulfation level-dependent manner. These opposing effects can be explained by our finding that the HS binding site is remote from the active site, which allows HS to specifically inhibit the collagenase activity without affecting the peptidase activity. At last, we show that structurally defined HS oligosaccharides effectively block osteoclast resorption of bone in vitro without inhibiting osteoclast differentiation, which suggests that HS-based oligosaccharide might be explored as a new class of selective CtsK inhibitor for many diseases involving exaggerated bone resorption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Biology, School of Dental Medicine, University at Buffalo, the State University of New York, Buffalo, NY 14214, USA.
- Macromolecular Structure Group, Epigenetics and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.
- Glycan Therapeutics Corp, 617 Hutton Street, Raleigh, NC 27606, USA.
- Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.
- Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
- Department of Oral Biology, School of Dental Medicine, University at Buffalo, the State University of New York, Buffalo, NY 14214, USA. Electronic address: dingxu@buffalo.edu.
Förderung
- NIGMS NIH HHS
- Intramural NIH HHS
- NIDCR NIH HHS
- NHLBI NIH HHS
- NIAMS NIH HHS
- NIH HHS
- U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences
- National Cancer Institute
Zitieren
APA
Zhang, X., Luo, Y., Hao, H., Krahn, J. M., Su, G., Dutcher, R., Xu, Y., Liu, J., Pedersen, L. C., & Xu, D. (2024). Heparan sulfate selectively inhibits the collagenase activity of cathepsin K. Matrix Biology. https://doi.org/10.1016/j.matbio.2024.03.005
Vancouver
Zhang X, Luo Y, Hao H, Krahn JM, Su G, Dutcher R, et al. Heparan sulfate selectively inhibits the collagenase activity of cathepsin K. Matrix Biology. 2024. doi:10.1016/j.matbio.2024.03.005
BibTeX
@article{Zhang2024,
author = {Zhang, Xiaoxiao and Luo, Yin and Hao, Huanmeng and Krahn, Juno M and Su, Guowei and Dutcher, Robert and Xu, Yongmei and Liu, Jian and Pedersen, Lars C and Xu, Ding},
title = {Heparan sulfate selectively inhibits the collagenase activity of cathepsin K},
journal = {Matrix Biology},
year = {2024},
doi = {10.1016/j.matbio.2024.03.005}
}
EUVIMED